Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Ampyra (dalfampridine)
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Estrogen treatment in multiple sclerosis.
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Rituximab (marketed as Rituxan), Information
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Multiple sclerosis in pregnancy.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Risks of immune system treatments.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »